Navigation Links
InspireMD Announces First Quarter 2012 Financial Results
Date:5/8/2012

he Company's major markets during the three months ended March 31, 2012, including Mexico, Israel, Germany, Poland and the Netherlands compared to the same period in 2011. 
  • Gross profit in the quarter was $0.6 million, a decrease of 28.3% or approximately $0.2 million, from $0.8 million during the same period in 2011. The gross margin in the quarter increased to 49.6% from 46.7% during the same period in 2011.
  • Total operating expenses were $3.7 million, compared to $2.0 million in the same period of 2011. This increase was mainly driven by share-based compensation of $0.8 million, increased R&D expenditures relating to the MASTER trial and planned FDA trials of $0.8 million, and other expenses of $0.1 million. 
  • Loss from operations in the quarter was $3.1 million, compared to a loss from operations of $1.2 million in the comparable period in 2011.
  • The net loss for the quarter was $3.1 million, or $0.05 per weighted average share, compared to a net loss of $1.9 million in the comparable period in 2011.
  • The Company ended the quarter with cash and cash equivalents of approximately $3.4 million, as compared to $5.1 million as of December 31, 2011.

    • Achievements in 1Q 2012

  • Enrollment continued in the MASTER Trial which is comparing MGuard™ with the standard of care in STEMI patients. As of May 4, 2012, 370 patients (out of 432 planned) were enrolled.
  • Positive clinical results were reported from the MICAMI trial of MGuard™ at the Cardiovascular Research Technologies (CRT) conference in Washington D.C. This randomized controlled trial showed a significant improvement in microvascular reperfusion for MGuard™ vs. bare metal stents.
  • Dr. James Barry was appointed to the Board of Directors as an independent director. Dr. Barry is a former senior executive at Boston Scientific and has a proven track record of bringing high value medical technolog
    '/>"/>

    • SOURCE InspireMD, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
    2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
    3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
    4. InspireMD Boosts MGuard Production Capacity
    5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
    6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
    7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
    8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
    9. InspireMD Announces Year-to-Date 2011 Progress
    10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
    11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
    (Date:5/16/2013)... -- OrthoView PSL will allow individual surgeons ... widely-used OrthoView digital templating software via the Cloud and ... started. OrthoView, the leading independent provider of ... dedicated to enabling orthopaedic surgeons in hospitals and private ... film is unavailable. Over 5,000 orthopaedic surgeons in the ...
    (Date:5/16/2013)... Developers of a pill bottle that wirelessly transmits ... grand prize winners in the Healthcare Innovation World Cup ... and organized by HITLAB . Winning team ... Langhauser and Mike Morena ... States will receive $50,000 in prize money. They ...
    Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5
    ... CLARA, Calif., March 7, 2011 Samplify Systems, Inc., ... medical, industrial, wireless, and scientific markets, has completed its ... enables the company to fund its rapid growth in ... new markets.  Participating in the round are Integrated Device ...
    ... plc (Nasdaq: WCRX ) today announced that its ... scheduled to speak at the Goldman Sachs Leveraged Finance Healthcare ... The presentation will be simultaneously webcast at ... available shortly thereafter at http://ir.wcrx.com/events.cfm . ...
    Cached Medicine Technology:Samplify Systems Completes Series B Funding 2Samplify Systems Completes Series B Funding 3
    (Date:5/18/2013)... May 18, 2013 Assisted living ... comes to safety and comfort of their residents. ... provides clients with an effective and cost-efficient solution ... is an integrated, turnkey communications solution that helps ... allowing residents independence and privacy. , The ...
    (Date:5/18/2013)... (PRWEB) May 18, 2013 Today, ... insurance agents’ role in Marketplaces . Zane ... traditional employer sponsored health benefits, is the leader ... and health reimbursement arrangements . , According ... and Human Services (HHS) recently released a much-anticipated ...
    (Date:5/18/2013)... FL (PRWEB) May 18, 2013 The ... to the special places we call home. These are the ... maps. They are the locations where the people are friendly ... show takes viewers off the highways and shares the best ... of both nations with an American sports and film celebrity. ...
    (Date:5/18/2013)... “World Healthcare IT Market: Trends & Forecast (2010 – ... and opportunities in North America, Europe, Asia, & Rest ... 89 market data tables , 20 ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers will ... IT market is expected to grow from $99.6 billion ...
    (Date:5/18/2013)... 2013 TheBeautyPlace.com answers important questions about ... is not a result of stress, nutrient deficiency or ... Magazine, 70% of men suffer from male patterned baldness. ... renowned for hair transplant surgery, but additionally carries a ... known as Bosley Professional Strength. Their product line is ...
    Breaking Medicine News(10 mins):Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3
    ... The Cosmetic Bootcamp LLC, the leading training ... is pleased to announced reduced tuition scholarships for ... resident in dermatology, plastic surgery, ophthalmology, oculoplastic surgery, ... economic conditions, the sponsors for the meeting have ...
    ... for millionsBIRMINGHAM, Ala., April 28 As many as 17.8 ... 2050 and 1.57 million will be blind from the disease, ... However, a new medical study by a group of ... University of Alabama Birmingham (UAB) indicates that with ...
    ... Md. (April 24, 2009) The Henry M. Jackson Foundation ... a one-of-a-kind publication intended to educate anesthesiology residents in ... techniques and acute pain medicine. Its aim is to ... combat trauma. , " The Military Advanced Regional ...
    ... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... president and chief executive officer, Hill-Rom. He will be ... New York City on Wednesday, May 13, 2009 at 2 ... via the internet link at http://ir.hill-rom.com/events.cfm ...
    ... BMP,Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" ... Baledge to its board of directors following,the Company,s annual ... Mr. Baledge has over two decades ... Mr. Baledge served as Executive Vice President and General,Counsel ...
    ... Annual Meeting , CHICAGO, April 28 Endo Pharmaceuticals ... clinical trial data in men with hypogonadism who were ... 750 mg) injection, a long-acting testosterone replacement therapy in ... Results showed that average testosterone levels were maintained within ...
    Cached Medicine News:Health News:New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement 2Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Hill-Rom to Present at the Bank of America 2009 Health Care Conference 2Health News:BMP Sunstone Appoints Les R. Baledge to Board of Directors 2Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 2Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 3Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 4Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 5
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    Inquire...
    VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
    Plastic Citrate Tube, .109M / 3.2%...
    Medicine Products: